Patents by Inventor Christoph Riemer

Christoph Riemer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of polymer powder compositions that can be redispersed in water and have cationic functionality, as flocculation aid
    Patent number: 10463991
    Abstract: The invention relates to the use of polymer powder compositions that can be redispersed in water and have cationic functionality, as flocculation aid, for example for dewatering waters or waste waters that are laden with solids.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: November 5, 2019
    Assignee: Wacker Chemie AG
    Inventors: Christoph Riemer, Manuela Brandmeier, Manfred Selig, Oliver Stratmann
  • USE OF POLYMER POWDER COMPOSITIONS THAT CAN BE REDISPERSED IN WATER AND HAVE CATIONIC FUNCTIONALITY, AS FLOCCULATION AID
    Publication number: 20180161699
    Abstract: The invention relates to the use of polymer powder compositions that can be redispersed in water and have cationic functionality, as flocculation aid, for example for dewatering waters or waste waters that are laden with solids.
    Type: Application
    Filed: October 6, 2015
    Publication date: June 14, 2018
    Inventors: Christoph Riemer, Manuela Brandmeier, Manfred Selig, Oliver Stratmann
  • Inhibitors for urokinase receptor
    Patent number: 6872702
    Abstract: The present invention concerns peptides as inhibitors of the binding of urokinase to the urokinase receptor. These peptides, which are preferably cyclic, are suitable as pharmaceutical agents for diseases that are mediated by urokinase and its receptor.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: March 29, 2005
    Assignee: Wilex AG
    Inventors: Horst Kessler, Heinrich Graeff, Manfred Schmitt, Viktor Magdolen, Olaf G. Wilhelm, Christoph Riemer, Markus Bürgle
  • Inhibitors of the urokinase receptor
    Publication number: 20040138110
    Abstract: The present invention concerns peptides as inhibitors of the binding of urokinase to the urokinase receptor. The peptides, which are preferably cyclic, are suitable as pharmaceutical agents for diseases that are mediated by urokinase and its receptor.
    Type: Application
    Filed: January 14, 2004
    Publication date: July 15, 2004
    Applicant: Wilex AG
    Inventors: Horst Kessler, Heinrich Graeff, Manfred Schmitt, Viktor Magdolen, Olaf G. Wilhelm, Christoph Riemer, Markus Burgle
  • Inhibitors for urokinase receptor
    Patent number: 6528619
    Abstract: The present invention provides peptides as inhibitors of the binding of urokinase to the urokinase receptor. The peptides have the general structural formula (I): X1-[X2]n-X3-X4-K-Y-F-X5-X6-I-X7-W-[X8]m  (I) in which X1, X2, X3, X4, X5, X6, X7 and X8 each denote an aminocarboxylic acid, n and m are each independently 0 or 1, K denotes an aminocarboxylic acid with a lysine side chain, Y denotes an aminocarboxylic acid with a tyrosine side chain, F denotes an aminocarboxylic acid with a phenyl-alanine side chain, I denotes an aminocarboxylic acid with an isoleucine side chain, W denotes an aminocarboxylic acid with a tryptophan side chain, and the monomeric building blocks are linked by —CONR1— or —NR1CO— bonds where R1 in each case independently denotes hydrogen, methyl or ethyl, and pharmaceutically compatible salts and derivatives thereof.
    Type: Grant
    Filed: January 10, 2000
    Date of Patent: March 4, 2003
    Assignee: Roche Diagnostics GmbH
    Inventors: Markus Bürgle, Heinrich Graeff, Horst Kessler, Viktor Magdolen, Bernhard König, Marcus Koppitz, Christoph Riemer, Manfred Schmitt, Ulrich Weidle